KDV B — Kdventures AB Share News
0.000.00%
Last trade - 00:00- SEK185.53m
- SEK138.12m
- SEK1.67m
Brief: Karolinska Development's Portfolio Co Secures Funding For Development Of Golexanolone
Brief: Karolinska Development Says Portfolio Company SVF Vaccines Initiates Clinical Phase 1 Study Of Its Universal COVID-19 Vaccine
Brief: Karolinska Development Q4 Net Result SEK 10 Million
Brief: Karolinska Development Portfolio Company Presents Preclinical Data
Brief: Karolinska Development's Ossdsign Presents Positive Long-Term Data For Ossdsign Cranial PSI
Brief: Karolinska Development Q3 Net Loss Widens To SEK 46.6 Mln
Brief: Karolinska Development Invests In Danish Dermatology Company Henlez
Brief: Karolinska Development’s Portfolio Company Umecrine Cognition Presents Positive Results
Brief: Karolinska Development's Portfolio Company Umecrine Cognition Secures Funding Ahead Of Phase 2 Study Of Golexanolone In Primary Biliary Cholangitis
Brief: Karolinska Development Portfolio Company AnaCardio Raises SEK 150 Million For Clinical Trial
Brief: Karolinska Development Appoints New CFO
Brief: Karolinska Development's Portfolio Company Initiates Clinical Phase 1 Program With PN-6047
Brief: Karolinska Development Q2 Net Loss At SEK 22.3 Mln
Brief: Karolinska Development Says Portfolio Company Umecrine Cognition Recruits Anders Karlsson As The New CEO
Brief: Karolinska Developments Portfolio Company Promimic And Danco Medical Form Joint Venture For US-Market
Brief: Karolinska Development Invests In Pharmnovo
Brief: Karolinska Development's Svenska Vaccinfabriken Presents Scientific Advancements At International Conference
Brief: Karolinska Development's Portfolio Company Presents Preclinical Results
Brief: Karolinska Development Invests In Breakthrough Drug Project